Discover open access scientific publications

Search, annotate, share and cite publications

Publications by G L Uy

A Phase 1 Study of Concomitant High-Dose Lenalidomide and 5-Azacitidine Induction in the Treatment of AML

Leukemia

English

Bortezomib Administered Pre-Auto-SCT and as Maintenance Therapy Post Transplant for Multiple Myeloma: A Single Institution Phase II Study

Bone Marrow Transplantation

Transplantation

Hematology

2008

English

Related publications

A Phase I Study of Midostaurin and Azacitidine in Relapsed and Elderly AML Patients

Clinical Lymphoma, Myeloma and Leukemia

English

Daunorubicin Dose in AML Induction

English

Phase I Dose Escalation Study of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

English

A Phase II Study of Oxaliplatin, Dose-Intense Capecitabine, and High-Dose Bevacizumab in the Treatment of Metastatic Colorectal Cancer

Clinical Colorectal Cancer

Oncology

Gastroenterology

2011

English

Azacitidine and Lenalidomide as an Alternative Treatment for Refractory Acute Myeloid Leukemia: A Case Report

Sao Paulo Medical Journal

Medicine

2014

English

Pretransplantation 5-Azacitidine in High-Risk Myelodysplastic Syndrome

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2014

English

Elderly Do Benefit From Induction Chemotherapy: High Dose Mitoxantrone Based (“5+1”) Induction Chemotherapy Regimen in Newly Diagnosed Acute Myeloid Leukemia

American Journal of Hematology

Hematology

2018

English

Association Between Methadone Dose and Concomitant Cocaine Use in Methadone Maintenance Treatment: A Register-Based Study

Substance Abuse: Treatment, Prevention, and Policy

English

Interest of the Association Azacitidine–lenalidomide as Frontline Therapy in High-Risk Myelodysplasia or Acute Myeloid Leukemia With Complex Karyotype

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by G L Uy

A Phase 1 Study of Concomitant High-Dose Lenalidomide and 5-Azacitidine Induction in the Treatment of AML

Bortezomib Administered Pre-Auto-SCT and as Maintenance Therapy Post Transplant for Multiple Myeloma: A Single Institution Phase II Study

Related publications

A Phase I Study of Midostaurin and Azacitidine in Relapsed and Elderly AML Patients

Daunorubicin Dose in AML Induction

Phase I Dose Escalation Study of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

A Phase II Study of Oxaliplatin, Dose-Intense Capecitabine, and High-Dose Bevacizumab in the Treatment of Metastatic Colorectal Cancer

Azacitidine and Lenalidomide as an Alternative Treatment for Refractory Acute Myeloid Leukemia: A Case Report

Pretransplantation 5-Azacitidine in High-Risk Myelodysplastic Syndrome

Elderly Do Benefit From Induction Chemotherapy: High Dose Mitoxantrone Based (“5+1”) Induction Chemotherapy Regimen in Newly Diagnosed Acute Myeloid Leukemia

Association Between Methadone Dose and Concomitant Cocaine Use in Methadone Maintenance Treatment: A Register-Based Study

Interest of the Association Azacitidine–lenalidomide as Frontline Therapy in High-Risk Myelodysplasia or Acute Myeloid Leukemia With Complex Karyotype